Carcinoma, Adenoid Cystic

2

Review clinical trials related to Carcinoma, Adenoid Cystic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma

The investigators aim at investigating in a prospective clinical trial whether using a Simoultaneous Integrated Boost of carbon ions treatment planning approach, improving the tumor dose conformation while lowering the unintended dose to the low-risk volume, can significantly reduce the probability of toxicity without affecting Local Control.

Participants needed: 42
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: CNAO National Center of Oncological HadrontherapyUpdated: Feb 13, 2025Locations: 1
Eligibility criteria

Histologically-proven primary head and neck ACC; [+9]

Local conditions contraindicating CIRT (e.g., active infection or previous histo... [+10]

Status: Recruiting

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

There is no clinical study on epidermal growth factor receptor tyrosine kinase inhibitors has been systematically conducted in adenoid cystic carcinoma. This is a phase II study EGFR TKIs in adenoid cystic carcinoma to evaluate its efficacy in this disease.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18-90Biological sex: AllType: InterventionalSponsor: Qingdao Central HospitalUpdated: Mar 29, 2023Locations: 1
Eligibility criteria

Histologically or cytologically confirmed adenoid cystic carcinoma [+9]

1. A patient with no measurable disease, or allergy to the EGFR TKIs 2. Prior ch...